MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer

FASEB Journal

Volumn 28, Issue 6, 2014, Pages 2696-2704

  Lei, Zhe ^a,b   Xu, Guili ^a,b   Wang, Longqiang ^a,b   Yang, Haiping ^a,b   Liu, Xia ^a,b   Zhao, Jun ^a,b   Zhang, Hong Tao ^a,b  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Suzhou Key Laboratory for Molecular Cancer Genetics   (China)

Author keywords

Cell proliferation; Epigenetic mechanism; miRNAs; NSCLC; p SMAD3

Indexed keywords

MICRORNA; MICRORNA 142 3P; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INHIBITION; CANCER RISK; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UNTRANSLATED REGION;

CELL PROLIFERATION; EPIGENETIC MECHANISM; MIRNAS; NSCLC; P-SMAD3;

3' UNTRANSLATED REGIONS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; EUKARYOTIC INITIATION FACTOR-3; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84901853564     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-247288     Document Type: Article

References (37)

1. Lei, Z., Liu, R. Y., Zhao, J., Liu, Z., Jiang, X., You, W., Chen, X. F., Liu, X., Zhang, K., Pasche, B., and Zhang, H. T. (2009) TGFBR1 haplotypes and risk of non-small-cell lung cancer. Cancer Res. 69, 7046-7052
2. Feng, J., Zhang, X., Zhu, H., Wang, X., Ni, S., and Huang, J. (2012) High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer. Am. J. Clin. Pathol. 138, 230-235
3. Massague, J. (1998) TGF-beta signal transduction. Annu. Rev. Biochem. 67, 753-791
4. Kitisin, K., Saha, T., Blake, T., Golestaneh, N., Deng, M., Kim, C., Tang, Y., Shetty, K., Mishra, B., and Mishra, L. (2007) Tgf-Beta signaling in development. Sci. STKE 2007, cm1
5. Shi, Y., and Massague, J. (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700 (Pubitemid 36724933)
6. Moses, H. L., Yang, E. Y., and Pietenpol, J. A. (1990) TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245-247
7. Gomis, R. R., Alarcon, C., He, W., Wang, Q., Seoane, J., Lash, A., and Massague, J. (2006) A FoxO-Smad synexpression group in human keratinocytes. Proc. Natl. Acad. Sci. U.S.A. 103, 12747-12752 (Pubitemid 44298632)
8. Pardali, K., Kurisaki, A., Moren, A., ten Dijke, P., Kardassis, D., and Moustakas, A. (2000) Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J. Biol. Chem. 275, 29244-29256 (Pubitemid 32043793)
9. Meulmeester, E., and Ten Dijke, P. (2011) The dynamic roles of TGF-beta in cancer. J. Pathol. 223, 205-218
10. Kim, W. S., Park, C., Jung, Y. S., Kim, H. S., Han, J., Park, C. H., Kim, K., Kim, J., Shim, Y. M., and Park, K. (1999) Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. Anticancer Res. 19, 301-306 (Pubitemid 29168253)
11. Park, C., Kim, W. S., Choi, Y., Kim, H., and Park, K. (2002) Effects of transforming growth factor beta (TGF-beta) receptor on lung carcinogenesis. Lung Cancer 38, 143-147
12. Colasante, A., Aiello, F. B., Brunetti, M., and di Giovine, F. S. (2003) Gene expression of transforming growth factor beta receptors I and II in non-small-cell lung tumors. Cytokine 24, 182-189 (Pubitemid 37330120)
13. Zhao, J., Liu, Z., Li, W., Liu, X., Chen, X. F., and Zhang, H. T. (2008) Infrequently methylated event at sites -362 to -142 inthe promoter of TGF beta R1 gene in non-small cell lung cancer. J. Cancer Res. Clin. Oncol. 134, 919-925
14. Zhang, H. T., Fei, Q. Y., Chen, F., Qi, Q. Y., Zou, W., Wang, J. C., Zhang, R. M., Tao, S. H., Chen, X. F., and Luo, Z. W. (2003) Mutational analysis of the transforming growth factor beta receptor type I gene in primary non-small cell lung cancer. Lung Cancer 40, 281-287 (Pubitemid 36627707)
15. Guo, H., Ingolia, N. T., Weissman, J. S., and Bartel, D. P. (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840
16. Wilson, R. C., and Doudna, J. A. (2013) Molecular mechanisms of RNA interference. Annu. Rev. Biophys. 42, 217-239
17. Sessa, R., and Hata, A. (2013) Role of microRNAs in lung development and pulmonary diseases. Pulm. Circ. 3, 315-328
18. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (Pubitemid 40094598)
19. Schneider, M. R. (2012) MicroRNAs as novel players in skin development, homeostasis and disease. Br. J. Dermatol. 166, 22-28
20. Wang, C., Wang, X., Liang, H., Wang, T., Yan, X., Cao, M., Wang, N., Zhang, S., Zen, K., Zhang, C., and Chen, X. (2013) miR-203 inhibits cell proliferation and migration of lung cancer cells by targeting PKCalpha. PLoS ONE 8, e73985
21. Butz, H., Racz, K., Hunyady, L., and Patocs, A. (2012) Crosstalk between TGF-beta signaling and the microRNA machinery. Trends Pharmacol. Sci. 33, 382-393
22. Wang, Y., Gu, J., Roth, J. A., Hildebrandt, M. A., Lippman, S. M., Ye, Y., Minna, J. D., and Wu, X. (2013) Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer, Cancer Res. 73, 4801-4809
23. Qian, S., Ding, J. Y., Xie, R., An, J. H., Ao, X. J., Zhao, Z. G., Sun, J. G., Duan, Y. Z., Chen, Z. T., and Zhu, B. (2008) MicroRNA expression profile of bronchioalveolar stem cells from mouse lung. Biochem. Biophys. Res. Commun. 377, 668-673
24. Lin, R. J., Xiao, D. W., Liao, L. D., Chen, T., Xie, Z. F., Huang, W. Z., Wang, W. S., Jiang, T. F., Wu, B. L., Li, E. M., and Xu, L. Y. (2012) MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J. Surg. Oncol. 105, 175-182
25. Boeri, M., Verri, C., Conte, D., Roz, L., Modena, P., Facchinetti, F., Calabro, E., Croce, C. M., Pastorino, U., and Sozzi, G. (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc. Natl. Acad. Sci. U.S.A. 108, 3713-3718
26. Kaduthanam, S., Gade, S., Meister, M., Brase, J. C., Johannes, M., Dienemann, H., Warth, A., Schnabel, P. A., Herth, F. J., Sultmann, H., Muley, T., and Kuner, R. (2013) Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients. Lung Cancer 80, 223-227
27. Varkonyi-Gasic, E., Wu, R., Wood, M., Walton, E. F., and Hellens, R. P. (2007) Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs. Plant Methods 3, 12
28. Huang, S. S., and Huang, J. S. (2005) TGF-beta control of cell proliferation. J. Cell. Biochem. 96, 447-462
29. Sun, J., Lei, Z., Liu, R. Y., Lu, Y., Zhuang, Z., Jiang, X., Qian, Q., Liu, Z., Zhao, J., and Zhang, H. T. (2011) A haplotype of TGFBR1 is predominantly found in non-small cell lung cancer patients displaying TGFBR1 allelic-specific expression. Oncol. Rep. 25, 685-691
30. Kim, I. Y., Ahn, H. J., Zelner, D. J., Shaw, J. W., Lang, S., Kato, M., Oefelein, M. G., Miyazono, K., Nemeth, J. A., Kozlowski, J. M., and Lee, C. (1996) Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin. Cancer Res. 2, 1255-1261 (Pubitemid 26299422)
31. Tokunaga, H., Lee, D. H., Kim, I. Y., Wheeler, T. M., and Lerner, S. P. (1999) Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients. Clin. Cancer Res. 5, 2520-2525 (Pubitemid 29437337)
32. Fukai, Y., Fukuchi, M., Masuda, N., Osawa, H., Kato, H., Nakajima, T., and Kuwano, H. (2003) Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int. J. Cancer 104, 161-166 (Pubitemid 36249790)
33. Dews, M., Fox, J. L., Hultine, S., Sundaram, P., Wang, W., Liu, Y. Y., Furth, E., Enders, G. H., El-Deiry, W., Schelter, J. M., Cleary, M. A., and Thomas-Tikhonenko, A. (2010) The myc-miR-17∼92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res. 70, 8233-8246
34. Tanaka, K., Kondo, K., Kitajima, K., Muraoka, M., Nozawa, A., and Hara, T. (2013) Tumor-suppressive function of proteintyrosine phosphatase non-receptor type 23 in testicular germ cell tumors is lost upon overexpression of miR142-3p microRNA. J. Biol. Chem. 288, 23990-23999
35. MacKenzie, T. N., Mujumdar, N., Banerjee, S., Sangwan, V., Sarver, A., Vickers, S., Subramanian, S., and Saluja, A. K. (2013) Triptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation. Mol. Cancer Ther. 12, 1266-1275
36. Dou, L., Li, J., Zheng, D., Li, Y., Gao, X., Xu, C., Gao, L., Wang, L., and Yu, L. (2013) MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene. Mol. Biol. Rep. 40, 6811-6819
37. Ling, N., Gu, J., Lei, Z., Li, M., Zhao, J., Zhang, H. T., and Li, X. (2013) microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma. Oncol. Rep. 30, 2111-2118